The rehabilitation day, measured
What fills a hospital day, what supported home cardiac care can offer, how hand stimulation and walking economy are measured, and what a cardiac risk marker can tell us.
Across five hospital wards, a research team recorded 6,804 observations of patients' daytime activity. Bedrooms dominated the picture. On rehabilitation wards, patients were on or in bed during 37%–45% of observations, and walking or standing remained uncommon. The study opens a question that an appointment list cannot answer: what opportunities for participation fill the rest of a person's day?
Today's reading room examines how care fits into life: activity during hospitalization, cardiac rehabilitation at home, hand practice after stroke and the energy needed to walk. Two further reports ask whether the word “minor” captures life after a cerebrovascular event, and how a measurement at the end of cardiac rehabilitation relates to later admission. Each result needs an outcome, a comparison and a boundary before it becomes useful advice.
All 88 registered sources and 15 study domains were checked. Discovery retrieved 816 journal-article records plus one book identifier; 148 article records were newly retrieved compared with October 14, including much older publications. All 12 inaccessible sources were retried without recovery. Two main reports were read in full; four main summaries use primary abstracts after access attempts. An ICU sedation trial was also read in full, while a developing stroke-support programme was checked at abstract level. Actual NICE recommendations, two recall communications and an education description were read separately. These checks do not establish complete coverage of unindexed work or licensed chapters.
The day contains more than the therapy session
At a regional Australian public hospital, researchers observed 151 inpatients across three acute and two rehabilitation wards. Behavioural mapping took place from 8 a.m. to 4 p.m. over five weekdays in March–April 2025. At each observation they recorded location, body position, activity and whether someone else was present.
Patients were in bedrooms for 85%–100% of observations across wards. On acute wards, 65%–100% of body-position observations involved being on or in bed; rehabilitation wards had lower proportions, 37%–45%. Walking or standing accounted for no more than 13% of body-position observations. Structured exercise accounted for 0%–14% of activity observations, and patients were alone during 50%–67% of observations.
These are ward-specific ranges across observation categories. They are not the percentage of people who never walked, a continuous eight-hour recording of every participant, or a measure of prescribed therapy minutes. Sitting, talking, thinking, rest and upright mobility also serve different purposes. A patient can be alone without being lonely, or sitting while participating meaningfully.
The useful clinical conversation concerns opportunities and barriers: when are supported activities available, what matters to the person, and what help or medical precautions are needed? The authors suggest that hospital routines may influence participation. Their observational design cannot determine why each patient was inactive, establish that rest was inappropriate, or prove that changing the environment improves recovery.
Clinical notes: observed behaviour, therapy dose and causation
The 6,804 records are repeated observations from 151 people. They must not be treated as thousands of independent patients. The abstract provides descriptive ward proportions without confidence intervals or an adjusted intervention effect. Differences between acute and rehabilitation wards may reflect case mix, illness severity, staffing, schedules or other factors; the study does not isolate their contributions.
One hospital, five weekdays and daytime sampling limit transferability to nights, weekends and other settings. Full sampling intervals, dependence between observations, diagnosis mix and observation reliability remained unavailable. This is a service-design signal, not evidence for unaided mobilization or a universal time-out-of-bed target. Safe activity plans should be agreed with the treating team.
Primary inpatient behavioural-mapping study · DOI: 10.1177/02692155261490491
Home rehabilitation means a supported programme
A trial assigned 111 patients, four to eight weeks after coronary artery bypass grafting, to twelve weeks of home telerehabilitation, centre-based cardiac rehabilitation or usual care: 37 per group. Home care used wearable sensors, an app, monitoring and coaching. Centre-based participants attended supervised sessions. This comparison concerns organized services, including support.
The primary outcomes were peak oxygen uptake, a measure of exercise capacity, and six-minute walk distance, a measure of walking performance. Among 101 completers, the abstract reports increases of 5.1 versus 4.8 mL/kg/min in peak oxygen uptake and 85.2 versus 81.5 metres in walking distance for home and centre care, respectively. Both programmes had statistically significant comparisons with usual care.
Those figures describe the reported improvements in the active groups; they are not the size of each programme's advantage over usual care. The abstract does not supply the control group's change or confidence intervals for the active comparisons. It reports no significant difference between home and centre care.
Adherence was reported as 92.1% at home and 85.3% at the centre, with no major adverse events. There is no reported statistical comparison of those adherence percentages. A small trial with short follow-up cannot establish safety for every patient or show fewer subsequent cardiac events.
For someone choosing a service, useful questions include clinical eligibility, monitoring, access to equipment, coaching, travel and the plan for symptoms during exercise. The findings support further use and evaluation of supported home delivery in this postoperative setting. They do not establish that an unsupervised exercise handout provides the same care.
Clinical notes: absence of a difference is not a noninferiority result
Formal equivalence or noninferiority requires a prespecified margin, an appropriate design and confidence intervals evaluated against that margin. Those details were unavailable in the abstract. “No significant difference” can also arise when a study lacks precision. The authors describe similar efficacy, but this edition makes no independent equivalence claim.
Ten randomized patients were not included among the reported completers. Their allocation, reasons for loss, missing-data analysis, detailed eligibility, programme intensity and complete harms procedures were unavailable. Secondary improvements in psychological scores, ejection fraction and quality of life were reported without numerical estimates; they are not reproduced as additional primary successes.
Primary home-versus-centre cardiac rehabilitation trial · DOI: 10.1097/HCR.0000000000001057
Measure what the hand can do
A three-arm trial enrolled 60 adults aged 45–65, six to eighteen months after stroke. Twenty received sensory electrical stimulation plus conventional physiotherapy, twenty received alternating electromyography-guided stimulation plus physiotherapy, and twenty received conventional physiotherapy alone. All completed the twelve-week intervention.
The approaches differ in their stimulation characteristics and voluntary-effort requirements. Electromyography records electrical activity in muscle; guided stimulation can use that activity as part of the treatment. Exact device settings and delivery procedures were not available for independent appraisal.
The primary outcome was the Action Research Arm Test (ARAT), which assesses upper-limb task performance. After adjustment for baseline score and age, the reported advantages over control were 12.05 points for sensory stimulation and 12.44 points for EMG-guided stimulation, both p<0.001. No significant difference was detected between the two active approaches. Confidence intervals were not supplied in the abstract.
The trial supplies a functional signal in this selected chronic-stroke population. It does not establish which approach is best for every patient, how durable the benefit is, or how much each participant improved in daily independence. A patient's goal might be handling a cup, fastening clothing or releasing an object; improvement on a structured test should be considered alongside that goal.
Clinical notes: a primary task outcome and secondary impairment scales
The abstract reports appropriate baseline adjustment for ARAT and nonparametric analyses for ordinal spasticity and strength scales. It also reports multiplicity corrections. Secondary findings generally favored stimulation, but finger-extensor strength was an exception. A change in muscle tone, strength and task performance should not be treated as three interchangeable measures.
Assessor blinding does not necessarily remove participant expectation or differences in treatment contact. Full allocation concealment, attention matching, intervention dose, adverse events and longer-term follow-up were unavailable after publisher retries. No independently verified clinical-importance threshold is applied here. The lack of a detected difference between active arms does not prove that they are equivalent.
Primary chronic-stroke hand-stimulation trial · DOI: 10.1177/10538135261496135
Walking farther and spending less energy are different gains
The metabolic cost of walking describes the energy needed to cover a distance, often expressed relative to body mass. It differs from maximum exercise capacity, walking speed and distance walked in six minutes. Two people can cover the same distance with different physiological demands.
A review of 27 randomized studies analyzed 36 intervention arms and 54 outcomes from 1,177 participants: 703 healthy adults and 474 people with neurological conditions. Sixteen studies involved healthy adults, nine involved stroke, and one each involved multiple sclerosis and Parkinson's disease. Exercise programmes included aerobic, resistance and other training.
The reported overall standardized effect favored improved walking economy: Hedges' g=0.40, 95% confidence interval 0.24–0.56. A standardized effect expresses change relative to variability across the measurements used. It does not mean forty-percent less energy expenditure or a forty-percent improvement in a particular person's walking.
The stroke subgroup was smaller and less certain: g=0.24, 95% CI −0.02 to +0.50, across nine studies and 353 participants. That interval spans no improvement and a favorable effect. It does not establish that exercise cannot benefit people after stroke. It also cannot justify transferring the pooled result, dominated by a different population, unchanged to an individual patient.
The review did not identify a dependable best training type, dose or intensity for this outcome. A failure to detect a moderator can reflect limited power. The clinical implication is to specify what is being targeted and measured: easier walking, greater capacity, faster performance or more participation may require different assessments.
Clinical notes: dependent outcomes, heterogeneity and an ecological association
The search extended through June 3, 2025. The authors used robust variance estimation to handle multiple outcomes and study arms, standardizing signs so positive effects indicated improvement. Overall heterogeneity was I²=46.1%. Seven studies had high risk of bias, eleven some concerns and nine low risk in the authors' assessment. This was not a uniform set of identical exercise prescriptions or measurement protocols.
Only one study each addressed multiple sclerosis and Parkinson's disease. There were no post-programme follow-up measurements establishing how long changes lasted. English-language and full-text availability restrictions, variation in testing and possible familiarity with treadmill measurement limit interpretation. No pooled percentage reduction, individual response prediction or exact exercise prescription can be derived from g alone.
Higher study-level mean body mass index was associated with smaller effects in meta-regression. That is a comparison between study groups, not proof that an individual's body size determines whether exercise will help. Ancillary secondary-outcome figures contained internal reporting inconsistencies and are not used for numerical claims here. The main report, methods, results, limitations, disclosures and actual primary table were checked; included trials, supplements and extracted datasets were not independently reanalyzed.
Primary walking-economy review · Complete report and tables · DOI: 10.1007/s40279-026-02553-x
“Minor” does not describe every part of recovery
A review examined how studies define transient ischaemic attack (TIA) and minor stroke, and how they measure cognitive, psychological and participation difficulties. The search covered work from 2013 through June 4, 2026, and included 190 articles comprising 64,638 participants.
Cognition appeared in 134 articles, depression in 71 and quality of life in 46. Fatigue appeared in 33, social participation in sixteen, return to work or education in fourteen, and communication impairment in eight. These categories overlap. They count articles examining an outcome, not the proportion of patients who experienced it.
Only 41 studies, 21.6%, examined the relevant impairments as primary outcomes. Definitions of TIA and minor stroke, measurement tools and cutoff scores varied substantially. The review therefore does not provide a single reliable prevalence estimate for every difficulty or a uniform recovery trajectory.
For patients, a brief neurological label should leave room to discuss concentration, communication, mood, fatigue and returning to work. For clinicians, a normal-looking or mildly affected motor examination does not answer every participation question. The review supports attention to these domains; it does not test whether one screening programme improves recovery.
Clinical notes: article counts, representation and outcome selection
There was underrepresentation of female participants and lower-middle- and low-income countries, while ethnicity was rarely reported. The aggregate count should not be assumed to represent that many unique, nonoverlapping individuals without the full study table. The abstract does not provide pooled treatment effects or confidence intervals.
A core outcome set could improve comparability, but this report does not establish a validated new screening battery. Full extraction tables, quality assessment and overlap between cohorts remained unavailable. TIA and minor stroke are not interchangeable diagnoses; the review's finding of inconsistent definitions is a reason to inspect eligibility before applying results.
Primary TIA and minor-stroke measurement review · DOI: 10.1177/02692155261490502
A prognostic clue at the transition out of rehabilitation
A Japanese single-centre study examined 83 patients completing late-recovery-phase cardiac rehabilitation. Phase angle is derived from bioelectrical impedance, a measurement of the body's response to a small electrical signal. It can be influenced by fluid status, nutritional state and other physiological factors. The researchers tested its association with subsequent unplanned admission.
During a median 615 days of follow-up, 21 patients, 25.3%, were readmitted. Higher completion phase angle was associated with a lower readmission hazard in an age- and sex-adjusted model: adjusted HR 0.49, 95% CI 0.26–0.93. Phase angle at programme initiation and change during the programme did not have statistically clear associations in their respective models.
The outcome was urgent or unplanned admission from any cause after rehabilitation ended, rather than only cardiac readmission. Seven admissions involved worsening heart failure, seven other cardiovascular disease, four infection and three other causes. The study follows people who completed a programme; it does not measure the effect of that programme against no rehabilitation.
A proposed marker's usefulness also depends on discrimination, calibration, validation and whether using it changes care beneficially. Phase angle's area under the ROC curve was 0.69, 95% CI 0.57–0.82, describing only modest discrimination in this sample. An association does not demonstrate that raising phase angle will prevent an admission.
Clinical notes: selection, limited adjustment and a tentative threshold
Of 144 potential participants, 37 could not undergo bioimpedance measurement, mainly because of implanted cardiac electronic devices, and 24 more lacked a completion measurement. Only fourteen of the final 83 were women. With 21 events, a single-centre sample and adjustment limited to age and sex in the main reported models, residual confounding and overoptimistic prediction remain concerns. Missing NT-proBNP data prevented its consistent inclusion in multivariable modeling.
NT-proBNP, a marker of cardiac strain, had higher discrimination: AUC 0.82, 95% CI 0.71–0.94, with a significant comparison against phase angle. Phase angle was not significantly different from exercise-capacity measures; that does not prove equal prediction or incremental value. The study did not establish external validation, calibration for individual absolute risks or benefit from a phase-angle-guided management strategy.
The authors discuss a possible rise in risk below roughly 5 degrees from an exploratory curve. This is not an independently validated clinical cutoff. Death before readmission was censored, which also matters when interpreting risk in a population with competing events. The main methods, results, Tables I–III, curve, limitations and disclosures were reviewed; no raw data or independent validation set was appraised.
Primary cardiac phase-angle cohort · Publisher record and full PDF · DOI: 10.2490/prm.20260057
Build a day around the person's goals and capacity
NICE's stroke-rehabilitation guidance recommends needs-based multidisciplinary therapy, ordinarily at least three hours daily on five days weekly. It also explicitly accommodates people unable or unwilling to participate at that duration: needed therapy should still be offered on at least five days. Sessions should follow agreed goals and account for medical needs, fatigue and psychological factors. These recommendations concern stroke care, not every patient in the mixed-ward study.
For upper-limb stimulation, the guideline advises against routine use for everyone, while allowing a professionally guided trial within comprehensive rehabilitation for selected people with contraction who cannot move the arm against resistance. Continued use depends on improvement in strength and functional practice. A new small trial should be interpreted alongside selection, goals and this broader guidance.
Telerehabilitation should fit the person's preferences and rehabilitation goals, with equipment, training and technical support as needed, plus monitoring of benefit and depressive symptoms. The cardiac trial concerns a different condition, but the practical questions about access and support remain useful. Recommendations 1.2.16–1.2.22, 1.3.1–1.3.3 and 1.13.14–1.13.23 were inspected; underlying evidence reviews were not independently appraised. Actual NICE stroke-rehabilitation recommendations.
Two studies whose status matters
SAVE-ICU randomized 786 ventilated adults with acute hypoxemic respiratory failure across fourteen Canadian ICUs; 780 entered the main analysis. An inhaled sedation strategy, predominantly isoflurane with intravenous drugs as needed, did not lower hospital mortality versus usual intravenous sedation: 161/379 versus 171/390 deaths; reported RR 0.98, 95% CI 0.84–1.14. Eleven further consent withdrawals explain the mortality denominators. Delirium- and coma-free days were lower by 0.95 days, 95% CI 0.22–1.69 fewer, and all five serious adverse events occurred in the inhaled group, with attribution uncertain. Secondary comparisons were not adjusted for multiple testing. Overall three-month quality-of-life and disability comparisons did not show a clear advantage. This open-label strategy trial does not isolate one drug's effect or establish equivalence; it is not a rehabilitation intervention. The main report and displayed outcome/harms tables were read; supplements and twelve-month recovery results were not reviewed. Primary trial record · Main SAVE-ICU report.
The ENRICH programme describes development of brief reviews for mild-to-moderate cognitive, mood, anxiety and fatigue changes after stroke, with referral for more severe or persistent needs. Interviews, a Delphi survey and workshops informed its design. Feasibility testing is underway; clinical effectiveness testing is planned. This is a developing care model, not a positive efficacy trial. Primary intervention-development report.
Check the exact product and the date of the action
An FDA-hosted company announcement published October 14, issued by Par Health on October 13, recalls 22 lots of argatroban injection, 250 mg/2.5 mL, 100 mg/mL, because of particulate matter. Argatroban is an anticoagulant used in specific settings involving heparin-induced thrombocytopenia. The notice directs hospital pharmacies and distributors to stop use and distribution of recalled stock and arrange returns. The product table lists NDCs 42023-182-01 and 42023-182-89; the lot and expiration must also match. This concerns the specified stock, not every argatroban product. The company reported no related adverse events as of its announcement. The actual text and all 22 table entries were read; label images were not inspected. FDA-hosted argatroban recall and complete lot table.
The FDA also updated the AVID IV start kit, KRIV26-02, lot 1658437 notice on October 14 to identify a Class I recall. The notice explicitly says affected products and recommendations have not changed. Its August 20 instructions call for stock checks, quarantine and destruction of the entire affected kit after response forms, superseding earlier component-removal instructions for that item. The issue involves potential fungal contamination associated with recalled ChloraPrep applicators. Do not confuse the AVID kit lot with the applicator lot. Actual FDA AVID kit communication.
The AAPM&R journal club remains listed for October 19, 7:30–8:30 p.m. Central, discussing autonomic symptoms and endothelial function after spinal-cord injury, and a review of knee-PRP injection adverse events. The course description states no credit offered. Its description and logistics were read; the linked papers, live discussion and any recording were not appraised for this edition. Official journal-club description.
Test the interpretation
A small trial reports improved exercise capacity in both supported home and centre-based rehabilitation, with no significant difference between them. Its abstract supplies no equivalence margin or confidence interval for the active comparison. Which statement is most defensible?
- The two services are proved equivalent for all postoperative patients.
- The reported findings are encouraging, but formal equivalence cannot be established from these data.
- Every patient should receive home rehabilitation without monitoring.
- A nonsignificant comparison proves neither service is effective.
Reveal answer and reasoning
B. The active programmes may both help compared with usual care, yet uncertainty remains about their difference. Equivalence requires a prespecified acceptable margin and sufficiently precise estimates. Patient selection, monitoring, access, adherence and follow-up also affect applicability.
Words worth keeping
- Behavioural mapping
- Repeated observations of what people are doing, where they are and who is with them.
- Peak oxygen uptake
- The highest oxygen-use rate measured during an exercise test, used to assess exercise capacity.
- ARAT
- The Action Research Arm Test, a structured assessment of upper-limb task performance.
- Walking economy
- The energy or oxygen required to walk a distance under specified testing conditions.
- Standardized effect size
- A result expressed relative to measurement variability; it is not a percentage change.
- Noninferiority
- A design testing whether a treatment is no worse than a comparator by more than a predefined margin.
- Discrimination
- How well a risk measure distinguishes people who later do and do not experience an outcome.
- Calibration
- How closely predicted probabilities agree with observed outcome frequencies.
- Hazard ratio
- A relative comparison of event rates during follow-up among people still free of that event.
- Heparin-induced thrombocytopenia
- An immune complication of heparin that can lower platelet counts and promote dangerous clotting.
References & the coverage record
- How inpatients spend their day: A behavioural mapping study of physical, cognitive and social participation across acute and rehabilitation wards. Clinical rehabilitation · PMID 42873669 · DOI 10.1177/02692155261490491
- Efficacy of Home-Based Telerehabilitation Versus Center-Based Cardiac Rehabilitation on Cardiopulmonary Function and Exercise Capacity in Patients After Coronary Artery Bypass Grafting: A RANDOMIZED CONTROLLED TRIAL. Journal of cardiopulmonary rehabilitation and prevention · PMID 42872613 · DOI 10.1097/HCR.0000000000001057
- Efficacy of Sensory Electrical Stimulation Versus Alternating Electromyography-Guided Electrical Stimulation on Functional Recovery of the Hand in Chronic Stroke: A Randomized Controlled Trial. NeuroRehabilitation · PMID 42873553 · DOI 10.1177/10538135261496135
- Effects of Exercise Training on the Metabolic Cost of Walking in Health and Disease: A Systematic Review and Meta-analysis. Sports medicine (Auckland, N.Z.) · PMID 42873454 · DOI 10.1007/s40279-026-02553-x
- Inconsistent definitions and outcome measurement: A systematic review of impairments following transient ischaemic attack and minor stroke. Clinical rehabilitation · PMID 42873670 · DOI 10.1177/02692155261490502
- Phase Angle at Completion of Cardiac Rehabilitation Predicts Unplanned All-cause Readmission: A Retrospective Cohort Study. Progress in rehabilitation medicine · PMID 42872289 · DOI 10.2490/prm.20260057
- Isoflurane-Based Inhaled Sedation in Mechanically Ventilated Adults With Acute Hypoxemic Respiratory Failure: The SAVE-ICU Randomized Clinical Trial. JAMA · PMID 42872958 · DOI 10.1001/jama.2026.18471
- Development of Enhanced Reviews of Psychological Changes After Stroke (ENRICH): A complex Intervention to Monitor and Support Self-Management of Post-Stroke Psychological Changes Within a Matched Care Model. Clinical rehabilitation · PMID 42873962 · DOI 10.1177/02692155261488767
Eight research reports were appraised: a prospective inpatient behavioural-mapping study, two rehabilitation randomized trials, a walking-economy meta-analysis, a TIA/minor-stroke measurement review, a retrospective cardiac phase-angle cohort, a pragmatic ICU sedation randomized trial and an intervention-development report. The complete main walking report was read through methods, results, discussion, limitations and disclosures, with the actual primary outcome table checked in its PDF and publisher table page. Its secondary-outcome text contains internally inconsistent ancillary figures, which are not used for numerical claims. Included trials, supplements and extracted datasets were not independently appraised or reanalyzed. The complete main phase-angle PDF, methods, Tables I–III, spline curve, limitations and disclosures were read; the outcome tables and curve were visually inspected. No raw data or external validation set was appraised. The complete main SAVE-ICU report, displayed Tables 1–3, methods, results, discussion, limitations and disclosures were read through verified publisher web access after direct curl access failed. Its supplements, original protocol, raw data, figure images and twelve-month outcomes were not appraised. Consent withdrawals, mixed sedative exposure and unadjusted secondary testing were distinguished. Ward mapping, home-versus-centre cardiac rehabilitation, hand stimulation, TIA/minor-stroke measurement and ENRICH use primary abstracts; the cardiac publisher page supplies only an abstract, and other publisher attempts failed or returned redirect stubs. Full methods and complete harms remained unavailable for those five reports. Actual NICE NG236 recommendations 1.2.16–1.2.22, 1.3.1–1.3.3 and 1.13.14–1.13.23 were read as established 2013/2023 guidance; the underlying evidence reviews were not appraised. The actual FDA-hosted Par Health argatroban company announcement and all 22 textual lot entries were read, not vial-label images. Company announcement October 13 and FDA posting October 14 are distinguished. The actual AVID kit notice was read: its October 14 Class I classification did not change the already-issued product instructions. An October 14 bladder-cancer indication expansion was inspected for triage, not summarized as a new rehabilitation treatment or separate randomized efficacy trial. The actual AAPM&R October 19 journal-club description and credit status were read from its course HTML; papers, lectures and recordings were not appraised. All 88 source statuses, all 15 domain queries, 148 newly retrieved article titles/dates and 38 portal comparisons were inspected. All twelve inaccessible sources were retried without recovery. Portal changes included nonclinical membership/exhibitor links, a publisher navigation refresh and an actionable argatroban recall; dynamic hashes alone are not updates. The Cuccurullo registry URL returned generic publisher navigation, not verified chapter content. Discovery comprises 816 article metadata records plus one book identifier. A focused 17-record search was screened, separating older publications, repeated work, protocols, preclinical and unrelated reports. All domain results were capped at twenty and truncated. Capped set changes are not publication dates or retractions, and a landing fetch is not full linked-content appraisal. Licensed chapters, paid course content and audio were unavailable or unreviewed. No physician review is recorded; no CME or official examination status is claimed.
The discovery window was 2026/09/15–2026/10/15. A journal index check can miss work not yet indexed. A retrieved landing page does not verify every linked publication, paid course, podcast or textbook chapter. Candidate counts are discovery records, not validated practice changes.
See every registered source and its status → · Download this edition’s machine-readable coverage record
Educational, not medical advice. Discuss treatment choices with your clinician. Sources and evidence evolve; each dated edition preserves what was checked for that issue.